Drug Molecule Info Idarubicin is a promising drug indicated as first-line treatment of Acute Myeloid Leukemia, a relatively rare disease claiming around 1.2% of total cancer deaths. It is initially treated with chemotherapy to induce remission or additionally, the patient may undergo hematopoietic stem cell transplant. This article will provide an overview of Idarubicin. Idarubicin is an analog of Daunorubicin which belongs to the category of antitumor antibiotics.
It is an anthracycline antileukemic agent mainly indicated for the management of acute myeloid leukemia, which is a cancer of the myeloid line of blood cells. A rapid growth of abnormal white blood cells that accumulate in the bone marrow and interfere with the production of normal blood cells which leads AML. It is the most common acute leukemia affecting adults and its incidence increases with age. Idarubicin in combination…
